Clinical profiles of Crohn’s disease (CD) and ulcerative colitis (UC) patients
| CD | UC | |
|---|---|---|
| *Assessment of disease activity using Crohn’s disease activity index (CDAI) in CD and clinical activity index (CAI) in UC. | ||
| 5-ASA, 5-aminosalicylic acid, SASP, salicylazosulphapyridine. | ||
| No of patients | 10 | 10 |
| Sex (F/M) | 4/6 | 6/4 |
| Age (y) (mean (range)) | 33.0 (21–51) | 39.4 (22–70) |
| Disease activity* | ||
| CDAI (mean (range)) | 224.8 (165–324) | — |
| CAI (mean (range)) | — | 9.2 (5–16) |
| Medication | ||
| 5-ASA or SASP | 9 | 8 |
| Steroid | 2 | 3 |
| Azathioprine | 3 | 1 |